StonvexLoading…
StonvexStonvexStonvexCore line items from AQB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $705.26K | $657.45K | $477.27K | $2.47M |
Operating Income | $-33.70M | $-32.09M | $-2.53M | $-13.67M |
Net Income | $-65.08M | $-50.51M | $-11.16M | $-27.56M |
EPS (Diluted) | $-16.87 | $-16.00 | $-2.90 | $-7.17 |
Total Assets | $117.79M | $127.44M | $176.18M | $187.55M |
Total Liabilities | $17.71M | $24.09M | $22.34M | $22.53M |
Cash & Equivalents | $500.43K | $728.34K | $2.59M | $8.20M |
Free Cash Flow OCF − CapEx | $-15.42M | $-10.74M | $-5.54M | $-93.13M |
Shares Outstanding | 3.87M | 3.87M | 3.86M | 3.85M |